School of Pharmacy

Publications in the Biomolecular Science and Medicinal Chemistry Division

Publications

Content
LAM, FRANKIE, BRADSHAW, TRACEY D., MAO, HUI, ROBERTS, SCOTT, PAN, YUANJIANG and WANG, SHUDONG, 2012. ZJU-6, a novel derivative of Erianin, shows potent anti-tubulin polymerisation and anti-angiogenic activities INVESTIGATIONAL NEW DRUGS. 30(5), 1899-1907

Content
HIRT, B.V., WATTIS, J.A.D., PRESTON, S.P. and LAUGHTON, C.A., 2012. The effects of a telomere destabilizing agent on cancer cell-cycle dynamics: integrated modelling and experiments Journal of Theoretical Biology. 295, 9–22

Content
CHAUDHURI, RIMA, CARRILLO, OLIVER, LAUGHTON, CHARLES ANTHONY and OROZCO, MODESTO, 2012. Application of Drug-Perturbed Essential Dynamics/Molecular Dynamics (ED/MD) to Virtual Screening and Rational Drug Design JOURNAL OF CHEMICAL THEORY AND COMPUTATION. 8(7), 2204-2214

Content
VERNALL, A.J., STODDART, L.A., BRIDDON, S.J., HILL, S.J. and KELLAM, B., 2012. Highly potent and selective fluorescent antagonists of the human adenosine A3 receptor based on the 1,2,4-triazolo[4,3-α]quinoxalin-1-one scaffold Journal of Medicinal Chemistry. 55(4), 1771-1782

Content
DALE CL, HILL SJ and KELLAM B, 2012. New potent, short-linker BODIPY-630/650 labelled fluorescent adenosine MedChemComm. 3, 333-338

Content
STODDART, L.A., VERNALL, A.J., DENMAN, J.L., BRIDDON, S.J., KELLAM, B. and HILL, S.J., 2012. Fragment screening at adenosine-A3 receptors in living cells using a fluorescence-based binding assay Chemistry & Biology. 19(9), 1105-1115

Content
ENAYAT S, RAVANBOD S, RASSOULZADEGAN M, JAZEBI M, TARIGHAT S, ALA F, EMSLEY J and OTHMAN M, 2012. A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease. Thrombosis and haemostasis. 108(5), 946-54

Content
LIU, XIANGRUI, LAM, FRANKIE, SHI, SHENHUA, FISCHER, PETER M and WANG, SHUDONG, 2012. In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83. Investigational new drugs. 30(3), 889-897

Content
SULTANA, R., MCNEILL, D.R., ABBOTTS, R., MOHAMMED, M.Z., ZDZIENICKA, M.Z., QUTOB, H., SEEDHOUSE, C., LAUGHTON, C.A., FISCHER, P.M., PATEL, P.M., WILSON, D.M. and MADHUSUDAN, S., 2012. Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors International Journal of Cancer. 131(10), 2433-2444

Content
ROXBURGH P, HOCK AK, DICKENS MP, MEZNA M, FISCHER PM and VOUSDEN KH, 2012. Small Molecules That Bind The Mdm2 Ring Stabilize And Activate P53. Carcinogenesis. (In Press.)

Content
HOLE, ALISON, BAUMLI, SONJA, SHAO, HAO, SHI, SHENHUA, PEPPER, CHRIS, FISCHER, PETER M., WANG, SHUDONG, ENDICOTT, JANE ANNE and NOBLE, MARTIN, 2012. Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity: J. Med. Chem. Journal of Medicinal Chemistry. Ahead of Print

Content
DOIDGE, RACHEL, MITTAL, SALONI, ASLAM, AKHMED and WINKLER, G. SEBASTIAAN, 2012. Deadenylation of cytoplasmic mRNA by the mammalian Ccr4-Not complex BIOCHEMICAL SOCIETY TRANSACTIONS. 40, 896-901

Content
DOIDGE R, MITTAL S, ASLAM A and WINKLER GS, 2012. Deadenylation of cytoplasmic mRNA by the mammalian Ccr4-Not complex. Biochemical Society transactions. 40(4), 896-901
Displaying 391 to 405 of 916
Previous … 25 26 27 28 29 … Next

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

For all enquiries please visit:
www.nottingham.ac.uk/enquiry